Acute myeloid leukemia trials in Argentina
3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleMocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
- Where
- Buenos Aires, Córdoba, La Plata
- Age
- 18 years to 75 years
- People
- 366 worldwide
- Run by
- Priothera SAS
See details and how to joinNCT05429632 - Phase 3Taking peopleStudy of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
- Where
- Adrogué, Buenos Aires, Córdoba, Salta
- Age
- 12 years and over
- People
- 468 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT07211958 · EU 2025-522279-27-00 - No phaseTaking peopleRWE of 1st Line Treatment With ATO/ATRA for Adult APL
- Where
- CABA, La Plata, Paraná, Posadas, Rawson
- Age
- 18 years and over
- People
- 50
- Run by
- Grupo Argentino de Tratamiento de la Leucemia Aguda
See details and how to joinNCT04897490